← Leaderboards
Elizabeth A Winzeler
University Of California, San Diego
$16,284,816
Attributed
$20,587,607
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,587,607 · 10
By mechanism
R01$18,190,121 · 6
P50$1,551,634 · 1
R21$658,152 · 2
R03$187,700 · 1
Top collaborators
- Debopam Chakrabarti6 shared
- Nathanael Schiander Gray6 shared
- Daniel E Goldberg3 shared
- Dyann F Wirth3 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Daniel E Goldberg$41,519,182
- Dyann F Wirth$23,065,036
- Weizhong Li$2,640,758
Others in their field
Top investigators on “Drug Resistance”
- Judith S. Currier · University Of California Los Angeles$207,752,958
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,910,108
- Ralph Parchment · Leidos Biomedical Research, Inc.$140,676,376
- Daniel R Kuritzkes · Brigham And Women'S Hospital$114,882,802
- Peter C Adamson · National Childhood Cancer Foundation$114,476,581
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,453,088
Research focus
Drug ResistancePlasmodium FalciparumMalariaPharmaceutical PreparationsParasitesGenome SequencingProteinsPlasmodiumEvolutionIn VitroBaseResistanceBloodDrug DevelopmentInfectionAntimalarialsBiologyLiverScreeningGenesWhole GenomeGenomicsParasite ResistanceDesign
Grant awards (40)
Defining the resistome in P. falciparum: evolution and mechanism$1,123,100
R01 · FY2025 · AI · contact PI
Plasmodium Protein Kinase Focused Antimalarials Discovery$755,961
R01 · FY2025 · AI
Defining the resistome in P. falciparum: evolution and mechanism$1,102,586
R01 · FY2024 · AI · contact PI
Plasmodium Protein Kinase Focused Antimalarials Discovery$762,579
R01 · FY2024 · AI
Discovery of long-acting, chemoprotective antimalarial compounds$685,970
R01 · FY2024 · AI · contact PI
Plasmodium Protein Kinase Focused Antimalarials Discovery$46,379
R01 · FY2024 · AI
Plasmodium Protein Kinase Focused Antimalarials Discovery$9,412
R01 · FY2024 · AI
Defining the resistome in P. falciparum: evolution and mechanism$1,083,911
R01 · FY2023 · AI · contact PI
Plasmodium Protein Kinase Focused Antimalarials Discovery$769,003
R01 · FY2023 · AI
Discovery of long-acting, chemoprotective antimalarial compounds$693,310
R01 · FY2023 · AI · contact PI
Plasmodium Protein Kinase Focused Antimalarials Discovery$801,255
R01 · FY2022 · AI
Discovery of long-acting, chemoprotective antimalarial compounds$699,371
R01 · FY2022 · AI · contact PI
Discovery of long-acting, chemoprotective antimalarial compounds$712,608
R01 · FY2021 · AI · contact PI
Exploring the parasite genomics of severe falciparum malaria in Mozambique$183,677
R21 · FY2021 · AI · contact PI
Discovery of long-acting, chemoprotective antimalarial compounds$741,668
R01 · FY2020 · AI · contact PI
Exploring the parasite genomics of severe falciparum malaria in Mozambique$237,100
R21 · FY2020 · AI · contact PI
Discovery of chemically validated malaria liver stage targets$454,343
R01 · FY2019 · AI · contact PI
Discovery of chemically validated malaria liver stage targets$454,343
R01 · FY2018 · AI · contact PI
PROJECT 4: ENVIRONMENT-GENOME INTERACTIONS$288,260
P50 · FY2018 · GM · contact PI
Discovery of chemically validated malaria liver stage targets$454,343
R01 · FY2017 · AI · contact PI
PROJECT 4: ENVIRONMENT-GENOME INTERACTIONS$285,291
P50 · FY2017 · GM · contact PI
Defining the targets of broad intervention antimalarial agents$636,473
R01 · FY2016 · AI · contact PI
PROJECT 4: ENVIRONMENT-GENOME INTERACTIONS$491,513
P50 · FY2016 · GM · contact PI
Discovery of chemically validated malaria liver stage targets$468,093
R01 · FY2016 · AI · contact PI
Defining the targets of broad intervention antimalarial agents$652,347
R01 · FY2015 · AI · contact PI
PROJECT 4: ENVIRONMENT-GENOME INTERACTIONS$486,570
P50 · FY2015 · GM · contact PI
Defining the targets of broad intervention antimalarial agents$659,642
R01 · FY2014 · AI · contact PI
Discovery of chemically validated malaria liver stage targets$387,500
R01 · FY2014 · AI · contact PI
Defining the targets of broad intervention antimalarial agents$648,140
R01 · FY2013 · AI · contact PI
Discovery of chemically validated malaria liver stage targets$364,250
R01 · FY2013 · AI · contact PI
Discovery of chemically validated malaria liver stage targets$387,292
R01 · FY2012 · AI · contact PI
Discovery of chemically validated malaria liver stage targets$473,750
R01 · FY2011 · AI · contact PI
Functional genomic tools for in vivo study of P. vivax$237,375
R21 · FY2010 · AI · contact PI
Experimental Annotation of the P. Falciparum Genome$440,665
R01 · FY2009 · AI · contact PI
Experimental Annotation of the P. Falciparum Genome$432,294
R01 · FY2008 · AI · contact PI
Experimental Annotation of the P. Falciparum Genome$440,667
R01 · FY2007 · AI · contact PI
Experimental Annotation of the P. Falciparum Genome$453,828
R01 · FY2006 · AI · contact PI
Experimental Annotation of the P. Falciparum Genome$395,038
R01 · FY2005 · AI
Discovery of Allelic Variation in Plasmodium falciparum$93,850
R03 · FY2004 · AI
Discovery of Allelic Variation in Plasmodium falciparum$93,850
R03 · FY2003 · AI